Ursodeoxycholic acid and Pegintron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ursodeoxycholic acid (ursodiol) and Pegintron (peginterferon alfa-2b). Common drug interactions include anaemia among females and neutrophil count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Ursodeoxycholic acid and Pegintron. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Ursodeoxycholic acid?

Ursodeoxycholic acid has active ingredients of ursodiol. It is often used in biliary cirrhosis primary. eHealthMe is studying from 7,528 Ursodeoxycholic acid users. Check the latest studies of Ursodeoxycholic acid.

What is Pegintron?

Pegintron has active ingredients of peginterferon alfa-2b. It is often used in hepatitis c. eHealthMe is studying from 10,326 Pegintron users. Check the latest studies of Pegintron.

On Jul, 25, 2026

33 people who take Ursodeoxycholic acid and Pegintron together, and have interactions are studied.

Ursodeoxycholic acid and Pegintron drug interactions.

What are the common drug interactions of Ursodeoxycholic Acid and Pegintron, by gender? *:

female:

Anaemia (lack of blood)
Decreased appetite
Nausea (feeling of having an urge to vomit)
Anxiety disorder
Blood creatinine increased
Haemoglobin decreased
Insomnia (sleeplessness)
Platelet count decreased
Drug eruption (adverse drug reaction of the skin)
Palpitations (feelings or sensations that your heart is pounding or racing)

male:

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Platelet count decreased
Insomnia (sleeplessness)
Pyrexia (fever)
Suicidal ideation
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Abdominal discomfort
Abdominal distension
Blood uric acid increased
Cytomegalovirus infection

What are the common drug interactions of Ursodeoxycholic Acid and Pegintron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anxiety disorder
Decreased appetite
Haemoglobin decreased
Insomnia (sleeplessness)
Nausea (feeling of having an urge to vomit)
Blood creatinine increased
Blood uric acid increased
Eczema asteatotic (severe dry skin- during the winter months and in the elderly)
Platelet count decreased
Urinary tract infection

40-49:

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Platelet count decreased
Schizophrenia (a mental disorder characterized by a breakdown of thought processes)

50-59:

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Blood creatinine increased
Erythema (redness of the skin)
Gastric ulcer (stomach ulcer)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Platelet count decreased
Rash
Rectal cancer (cancer of rectum)
Renal disorder (kidney disease)

60+:

Anaemia (lack of blood)
Platelet count decreased
Palpitations (feelings or sensations that your heart is pounding or racing)
Rash
Depressive symptom
Insomnia (sleeplessness)
Pyrexia (fever)
Renal disorder (kidney disease)
Suicidal ideation
Hepatitis b

What are the existing conditions these people have? *

Hyperuricaemia (level of uric acid in the blood that is abnormally high): 5 people, 15.15%
Diabetes: 5 people, 15.15%
Type 2 Diabetes: 4 people, 12.12%
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 4 people, 12.12%
High Blood Pressure: 3 people, 9.09%
High Blood Cholesterol: 3 people, 9.09%
Insomnia (sleeplessness): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Ursodeoxycholic acid and Pegintron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously